Clinic
Family Medicine Associates P a
Family Medicine Associates P a was paid $3.97M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoFAMILY MEDICINE ASSOCIATES P A
MISSION, TX 78572
MISSION, TX 78572
33aNPI1295808293assigned 11/16/2006
33bProvider typeClinic/Center
28Total paid$3.97M
24GClaims175,601
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Texas
Rank by total paid#9 of 176
Median peer was paid$26K
This provider vs. median150×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,538 | $82K | |
| 2019 | 4,648 | $114K | |
| 2020 | 12,798 | $198K | |
| 2021 | 40,228 | $871K | |
| 2022 | 56,667 | $1.40M | |
| 2023 | 37,406 | $831K | |
| 2024incomplete | 19,316 | $465K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 31,020 | 23,895 | $985K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 11,489 | 9,537 | $422K |
| S8301 | Infection control supplies, not otherwise specified | 9.1% | 11,105 | 9,671 | $361K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.4% | 8,713 | 7,887 | $332K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.4% | 2,391 | 2,273 | $174K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.4% | 2,434 | 2,347 | $174K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.0% | 12,565 | 5,733 | $158K |
| 99444 | 3.8% | 2,771 | 863 | $151K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.8% | 2,037 | 1,924 | $150K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.0% | 1,755 | 1,662 | $118K |
| 99442 | 2.6% | 5,750 | 2,392 | $102K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 2,624 | 2,318 | $101K |
108 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.7% | 847 | $69K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.6% | 7,421 | $64K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 1,239 | $51K |
| 99350 | Prolong home eval add 15m | 1.2% | 1,969 | $49K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 885 | $47K |
| 99091 | 1.0% | 545 | $41K | |
| 99000 | <1% | 4,307 | $38K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,950 | $35K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,538 | $32K |
| 99422 | <1% | 1,883 | $32K | |
| 99349 | <1% | 709 | $28K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,379 | $24K |
| 59430 | <1% | 234 | $19K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,423 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,437 | $17K |
| 90688 | <1% | 3,559 | $14K | |
| 90670 | <1% | 1,586 | $14K | |
| 90461 | <1% | 3,437 | $13K | |
| 81003 | <1% | 6,362 | $11K | |
| 99460 | <1% | 131 | $9K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 2,326 | $9K |
| 59514 | <1% | 13 | $9K | |
| 99423 | <1% | 223 | $9K | |
| 87807 | <1% | 798 | $8K | |
| 99381 | <1% | 125 | $8K | |
| 90651 | <1% | 641 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 107 | $6K |
| 82947 | <1% | 2,589 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 89 | $5K |
| 86769 | <1% | 198 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 83 | $5K |
| 90681 | <1% | 606 | $4K | |
| 90723 | <1% | 1,081 | $4K | |
| 76801 | <1% | 29 | $3K | |
| 90620 | <1% | 379 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 46 | $2K |
| 90715 | <1% | 192 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 37 | $2K |
| 96160 | <1% | 3,190 | $2K | |
| 99462 | <1% | 53 | $2K | |
| 97169 | <1% | 40 | $1K | |
| 90734 | <1% | 481 | $1K | |
| 81025 | <1% | 176 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 19 | $1K |
| 90648 | <1% | 1,478 | $967.15 | |
| 99497 | <1% | 150 | $901.83 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 42 | $868.94 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 3,926 | $825.00 |
| 99385 | <1% | 13 | $823.70 | |
| 85018 | <1% | 548 | $780.28 | |
| 90710 | <1% | 162 | $723.12 | |
| 90633 | <1% | 751 | $671.45 | |
| 99050 | <1% | 42 | $612.88 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 42 | $539.60 |
| 80503 | <1% | 29 | $514.50 | |
| 99344 | <1% | 103 | $408.68 | |
| 99457 | <1% | 397 | $371.02 | |
| 96101 | <1% | 25 | $297.92 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 183 | $265.91 |
| 86580 | <1% | 27 | $195.87 | |
| 99458 | <1% | 399 | $181.31 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 789 | $168.51 |
| 0011A | <1% | 13 | $160.00 | |
| 99443 | <1% | 52 | $98.53 | |
| 82950 | <1% | 19 | $75.81 | |
| 81002 | <1% | 30 | $64.24 | |
| 90662 | <1% | 148 | $57.45 | |
| A6453 | Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard | <1% | 246 | $20.74 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,565 | $20.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 26 | $11.95 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 25 | $11.19 |
| 80061 | Lipid panel | <1% | 13 | $7.66 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 754 | $0.01 |
| 2000F | <1% | 452 | $0.01 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 645 | $0.01 |
| 3074F | 0% | 896 | $0.00 | |
| 0503F | 0% | 88 | $0.00 | |
| 1036F | 0% | 460 | $0.00 | |
| 3079F | 0% | 296 | $0.00 | |
| 3080F | 0% | 211 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 157 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 111 | $0.00 |
| 90696 | 0% | 89 | $0.00 | |
| 1170F | 0% | 72 | $0.00 | |
| 1101F | 0% | 228 | $0.00 | |
| 82044 | 0% | 12 | $0.00 | |
| 1111F | 0% | 28 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 180 | $0.00 |
| 99345 | Prolong home eval add 15m | 0% | 49 | $0.00 |
| G8599 | Aspirin or another antiplatelet therapy not used, reason not given | 0% | 12 | $0.00 |
| 90698 | 0% | 14 | $0.00 | |
| 91301 | 0% | 14 | $0.00 | |
| 90716 | 0% | 44 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 97 | $0.00 |
| 0502F | 0% | 733 | $0.00 | |
| 99072 | 0% | 202 | $0.00 | |
| 3077F | 0% | 175 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 103 | $0.00 |
| 80500 | 0% | 88 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 378 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 430 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 15 | $0.00 |
| 3078F | 0% | 672 | $0.00 | |
| 3288F | 0% | 425 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 35 | $0.00 |
| 90707 | 0% | 42 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 27 | $0.00 |
| 90700 | 0% | 108 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMURILLO, JAVIER (PRESIDENT)